tiprankstipranks
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
Holding LFCR?
Track your performance easily

Lifecore Biomedical (LFCR) Income Statement

126 Followers

Lifecore Biomedical Income Statement

Last quarter (Q1 2025), Lifecore Biomedical's total revenue was $24.70M, an increase of 0.75% from the same quarter last year. In Q1, Lifecore Biomedical's net income was $-15.42M. See Lifecore Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
May 24May 23May 22May 22May 21
Total Revenue
$ 128.44M$ 128.26M$ 103.27M$ 111.27M-$ 100.87M
Cost of Revenue
$ 83.94M$ 86.41M$ 75.28M$ 72.20M-$ 61.94M
Gross Profit
$ 44.51M$ 41.85M$ 27.98M$ 39.07M-$ 38.94M
Operating Expense
$ 56.32M$ 50.69M$ 49.78M$ 42.50M-$ 50.60M
Operating Income
$ -11.81M$ -8.84M$ -21.80M$ -11.79M-$ -134.00K
Net Non Operating Interest Income Expense
$ -4.28M$ -3.57M$ -3.95M$ 15.47M-$ -10.34M
Other Income Expense
$ -37.12M$ -36.45M$ 24.90M$ -1.78M-$ 999.00K
Pretax Income
$ 5.78M$ 9.51M$ -63.93M$ -20.69M-$ -11.47M
Tax Provision
$ 70.00K$ 183.00K$ 308.00K$ -5.21M-$ -6.35M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 7.34M$ 15.09M$ -98.40M$ -116.72M-$ -32.29M
Basic EPS
$ 0.22$ 0.40$ -3.32$ -3.31-$ -1.12
Diluted EPS
$ 0.14$ 0.32$ -3.32$ -3.31-$ -1.12
Basic Average Shares
$ 122.39M$ 30.47M$ 29.96M$ 29.47M-$ 29.29M
Diluted Average Shares
$ 150.50M$ 36.66M$ 29.96M$ 29.47M-$ 29.29M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 140.26M$ 137.10M$ 125.06M$ 114.70M$ -227.08M$ 171.68M
Net Income From Continuing And Discontinued Operation
$ 6.54M$ 12.01M$ -99.56M$ -116.72M-$ -32.29M
Normalized Income
$ 23.97M$ 11.61M----
Interest Expense
------
EBIT
$ 2.22M$ 9.89M$ -63.58M$ -5.14M-$ -20.85M
EBITDA
$ 10.90M$ 18.75M$ -50.40M$ 12.93M-$ -987.00K
Currency in USD

Lifecore Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis